Barnes PJ: Chronic obstructive pulmonary disease: a growing but neglected global epidemic. PLoS Med. 2007, 4: e112.
Article
PubMed
PubMed Central
Google Scholar
Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S: Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006, 27: 397-412.
Article
CAS
PubMed
Google Scholar
Wedzicha JA, Seemungal TA: COPD exacerbations: defining their cause and prevention. Lancet. 2007, 370: 786-796.
Article
PubMed
Google Scholar
Nannini L, Cates C, Lasserson T, Poole P: Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007, 4: CD003794.
PubMed
Google Scholar
Yang IA, Fong KM, Sim EH, Black PN, Lasserson TJ: Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007, 2: CD002991.
PubMed
Google Scholar
Wilt TJ, Niewoehner D, Macdonald R, Kane RL: Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline. Ann Intern Med. 2007, 147: 639-653.
Article
PubMed
Google Scholar
Tunis SR, Stryer DB, Clancy CM: Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. Jama. 2003, 290: 1624-1632.
Article
CAS
PubMed
Google Scholar
Rothman KJ, Michels KB: The continuing unethical use of placebo controls. New Engl J Med. 1994, 331: 394-398.
Article
CAS
PubMed
Google Scholar
American Thoracic Society and European Respiratory Society: Standards for the diagnosis and treatment of patients with chronic obstructive pulmonary disease. 2007, [http://www.ers-education.org/pages/default.aspx?id=725]
Google Scholar
Suissa S, McGhan R, Niewoehner D, Make B: Inhaled corticosteroids in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007, 4: 535-542.
Article
CAS
PubMed
Google Scholar
Nannini L, Cates C, Lasserson T, Poole P: Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007, 4: CD006829.
PubMed
Google Scholar
Nannini L, Cates C, Lasserson T, Poole P: Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007, 4: CD006826.
PubMed
Google Scholar
Berlin JA, Santanna J, Schmid CH, Szczech LA, Feldman HI: Individual patient-versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med. 2002, 21: 371-387.
Article
PubMed
Google Scholar
Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J: Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. New Engl J Med. 2007, 356: 775-789.
Article
CAS
PubMed
Google Scholar
Caldwell DM, Ades AE, Higgins JP: Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ. 2005, 331: 897-900.
Article
PubMed
PubMed Central
Google Scholar
Bucher HC, Guyatt GH, Griffith LE, Walter SD: The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997, 50: 683-691.
Article
CAS
PubMed
Google Scholar
Lu G, Ades AE: Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004, 23: 3105-3124.
Article
CAS
PubMed
Google Scholar
Lumley T: Network meta-analysis for indirect treatment comparisons. Stat Med. 2002, 21: 2313-2324.
Article
PubMed
Google Scholar
Suissa S: Statistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006, 173: 842-846.
Article
PubMed
Google Scholar
Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M, Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium: Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med. 2007, 146: 545-555.
Article
PubMed
Google Scholar
Beeh KM, Beier J, Buhl R, Stark-Lorenzen P, Gerken F, Metzdorf N: Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities. Pneumologie. 2006, 341-346.
Google Scholar
Bourbeau J, Rouleau MY, Boucher S: Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease. Thorax. 1998, 53: 477-482.
Article
CAS
PubMed
PubMed Central
Google Scholar
Boyd G, Morice AH, Pounsford JC, Siebert M, Peslis N, Crawford C: An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD). Eur Respir J. 1997, 10: 815-821.
CAS
PubMed
Google Scholar
Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S: Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax. 2003, 58: 399-404.
Article
CAS
PubMed
PubMed Central
Google Scholar
Burge PS, Calverley PMA, Jones PW, Spencer S, Anderson JA, Maslen TK: Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial. BMJ. 2000, 320: 1297-1303.
Article
CAS
PubMed
PubMed Central
Google Scholar
Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C: Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2003, 361: 449-456.
Article
CAS
PubMed
Google Scholar
Calverley PM, Boonsawat W, Cseke Z, Zhong N, Peterson S, Olsson H: Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J. 2003, 22: 912-919.
Article
CAS
PubMed
Google Scholar
Calverley PM, Lee A, Towse L, van NJ, Witek TJ, Kelsen S: Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Thorax. 2003, 58: 855-860.
Article
CAS
PubMed
PubMed Central
Google Scholar
Campbell M, Eliraz A, Johansson G, Tornling G, Nihlen U, Bengtsson T, Rabe KF: Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease. Respir Med. 2005, 99: 1511-1520.
Article
PubMed
Google Scholar
Celli B, Halpin D, Hepburn R, Byrne N, Keating ET, Goldman M: Symptoms are an important outcome in chronic obstructive pulmonary disease clinical trials: results of a 3-month comparative study using the Breathlessness, Cough and Sputum Scale (BCSS). Respir Med. 2003, 97 (Suppl A): S35-43.
Article
PubMed
Google Scholar
Chapman KR, Arvidsson P, Chuchalin AG, Dhillon DP, Faurschou P, Goldstein RS, Kuipers AF, International study group: The addition of salmeterol 50 mug bid to anticholinergic treatment in patients with COPD: A randomized, placebo controlled trial. Can Respir J. 2002, 3: 178-185.
Article
Google Scholar
Covelli H, Bhattacharya S, Cassino C, Conoscenti C, Kesten S: Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary disease. Pharmacotherapy. 2005, 25: 1708-1718.
Article
CAS
PubMed
Google Scholar
Dahl R, Greefhorst LA, Nowak D, Nonikov V, Byrne AM, Thomson MH, Till D, Della CG, Formoterol in Chronic Obstructive Pulmonary D: Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001, 164: 778-784.
Article
CAS
PubMed
Google Scholar
Dusser D, Bravo M-L, Iacono P, on behalf the MISTRAL study group: The effect of tiotropium on exacerbations and airflow in patients with COPD. Eur Respir J. 2006, 27 (3): 547-555.
Article
CAS
PubMed
Google Scholar
Donohue JF, Van Noord JA, Bateman ED, Langley SJ, Lee A, Witek TJ, Kesten S, Towse L: A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest. 2002, 1: 47-55.
Article
Google Scholar
Littner MR, Ilowite JS, Tashkin DP, Friedman M, Serby CW, Menjoge SS, Witek TJ: Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000, 161: 1136-42.
Article
CAS
PubMed
Google Scholar
Mahler DA, Donohue JF, Barbee RA, Goldman MD, Gross NJ, Wisniewski ME, Yancey SW, Zakes BA, Rickard KA, Anderson WH: Efficacy of salmeterol xinafoate in the treatment of COPD. Chest. 1999, 115: 957-965.
Article
CAS
PubMed
Google Scholar
Mahler DA, Wire P, Horstman D, Chang C, Yates J, Fischer T, Shah T: Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002, 166: 1084-1091.
Article
PubMed
Google Scholar
Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JA, Korducki L, Cassino C, Kesten S: Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial. Ann Intern Med. 2005, 143: 317-326.
Article
CAS
PubMed
Google Scholar
Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, Efthimiou J: Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructuve pulmonary disease. Lancet. 1998, 351: 773-780.
Article
CAS
PubMed
Google Scholar
Paggiaro PL, Vagaggini B, Di FA, Zingoni M, Fano M, Biraghi M: Efficacy of nebulized flunisolide combined with salbutamol and ipratropium bromide in stable patients with moderate-to-severe chronic obstructive pulmonary disease. Respiration. 2006, 73 (5): 603-609.
Article
CAS
PubMed
Google Scholar
Rossi A, Kristufek P, Levine BE, Thomson MH, Till D, Kottakis J, Della CG: Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD. Chest. 2002, 121: 1058-1069.
Article
CAS
PubMed
Google Scholar
Stockley RA, Chopra N, Rice L: Addition of salmeterol to existing treatment in patients with COPD: a 12 month study. Thorax. 2006, 61: 122-128.
Article
CAS
PubMed
PubMed Central
Google Scholar
Szafranski W, Cukier A, Ramirez A, Menga G, Sansores R, Nahabedian S, Peterson S, Olsson H: Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J. 2003, 21: 74-81.
Article
CAS
PubMed
Google Scholar
van der Valk , Monninkhof E, van der PJ, Zielhuis G, van HC: Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study. Am J Respir Crit Care Med. 2002, 166: 1358-1363.
Article
PubMed
Google Scholar
Van Noord JA, De Munck DRAJ, Bantje T, Hop WCJ, Akveld MLM, Bommer AM: Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium. Eur Respir J. 2000, 15 (5): 878-885.
Article
CAS
PubMed
Google Scholar
Wadbo M, Lofdahl CG, Larsson K, Skoogh BE, Tornling G, Arwestrom E, Bengtsson T, Strom K, Swedish Society of Respiratory Medicine: Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study. Eur Respir J. 2002, 20: 1138-1146.
Article
CAS
PubMed
Google Scholar
Baumgartner RA, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Hanrahan JP: Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial. Clin Ther. 2007, 29: 261-278.
Article
CAS
PubMed
Google Scholar
Briggs DD, Covelli H, Lapidus R, Bhattycharya S, Kesten S, Cassino C: Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD. Pulm Pharmacol Ther. 2005, 18: 397-404.
Article
CAS
PubMed
Google Scholar
Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T: A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J. 2002, 19: 217-224.
Article
CAS
PubMed
Google Scholar
Hanania NA, Darken P, Horstman D, Reisner C, Lee B, Davis S, Shah T: The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. Chest. 2003, 124: 834-843.
Article
CAS
PubMed
Google Scholar
Kardos P, Wencker M, Glaab T, Vogelmeier C: Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007, 175: 144-149.
Article
CAS
PubMed
Google Scholar
Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA: The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med. 2008, 177: 19-26.
Article
CAS
PubMed
Google Scholar
Weir DC, Bale GA, Bright P, Sherwood Burge P: A double-blind placebo-controlled study of the effect of inhaled beclomethasone dipropionate for 2 years in patients with nonasthmatic chronic obstructive pulmonary disease. Clin Exp Allergy. 1999, 29 (Suppl 2): 125-128.
Article
CAS
PubMed
Google Scholar
Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA: Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987, 106: 196-204.
Article
CAS
PubMed
Google Scholar
Akl EA, Grant BJ, Guyatt GH, Montori VM, Schunemann HJ: A decision aid for COPD patients considering inhaled steroid therapy: development and before and after pilot testing. BMC Med Inform Decis Mak. 2007, 7: 12.
Article
PubMed
PubMed Central
Google Scholar
Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E, BOLD Collaborative Research Group: International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007, 370: 741-750.
Article
PubMed
Google Scholar
Viejo-Banuelos JL, Pueyo-Bastida A, Fueyo-Rodriguez A: Characteristics of outpatients with COPD in daily practice: The E4 Spanish project. Respir Med. 2006, 100: 2137-2143.
Article
PubMed
Google Scholar
Fritsch K, Jacot ML, Klarer A, Wick F, Bruggmann P, Krause M, Thurnheer R: Adherence to the Swiss guidelines for management of COPD: experience of a Swiss teaching hospital. Swiss Med Wkly. 2005, 135: 116-121.
CAS
PubMed
Google Scholar
Scanlon PD, Connett JE, Wise RA, Tashkin DP, Madhok T, Skeans M, Carpenter PC, Bailey WC, Buist AS, Eichenhorn M, Kanner RE, Weinmann G, Lung Health Study Research Group: Loss of bone density with inhaled triamcinolone in Lung Health Study II. Am J Respir Crit Care Med. 2004, 170: 1302-1309.
Article
PubMed
Google Scholar
Pocock SJ: Safety of drug-eluting stents: demystifying network meta-analysis. Lancet. 2007, 370 (9605): 2099-2100.
Article
PubMed
Google Scholar
Deeks JJ, Altman DG: Effect measures for meta-analysis of trials with binary outcomes. Systematic Reviews in Health Care. Edited by: Egger M, Smith G, Altman D. 2001, London: BMJ Publishing Group, 313-335. 2
Chapter
Google Scholar
Stewart LA, Tierney JF: To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof. 2002, 25: 76-97.
Article
PubMed
Google Scholar